Beech Tree Labs, Inc.

We address unmet medical needs affecting the life of millions of people by restoring the body’s healthy equilibrium.

Founded 2005

Providence, United States 1 employees Series B Total: $8.46M Biopharma, Biotechnology +1

Beech Tree Labs, Inc., founded in 2005, is a United States-based company operating in the Biopharma, Biotechnology, and Pharmaceutical industries. The company is dedicated to addressing unmet medical needs by restoring the body’s healthy equilibrium, a mission encapsulated in its slogan: "We address unmet medical needs affecting the life of millions of people by restoring the body’s healthy equilibrium."

Over its more than 15 years of existence, Beech Tree Labs has focused on developing proprietary formulations that modulate the body’s signals to restore balance. As of the last known financial activity, the company secured a $7.00M Series B investment on 09 December 2010. While specific investor details for this round are not disclosed, this investment underscores the potential recognition of the company's innovative approach in the industry.

Overall, Beech Tree Labs' focus on addressing crucial medical needs with significant market potential makes it a noteworthy entity in the realm of healthcare innovation.

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	$7.00M	-		09 Dec 2010
Venture Round	$1.46M	-		15 Mar 2010

Funding Stage

Amount

Investors

Lead Investors

Date

Series B

$7.00M

09 Dec 2010

Venture Round

$1.46M

15 Mar 2010

FAQ About Beech Tree Labs, Inc.

We address unmet medical needs affecting the life of millions of people by restoring the body’s healthy equilibrium.

Beech Tree Labs, Inc. was founded in 2005.

Beech Tree Labs, Inc. is headquartered in Providence, United States.

Beech Tree Labs, Inc. operates in Biopharma, Biotechnology and Pharmaceutical. Its work centres on unmet medical needs, healthy equilibrium, pharmaceutical development and nutraceutical formulations. Its customers include Biotech Companies, Pharmaceutical Companies and Healthcare Institutions.

Beech Tree Labs, Inc. has a B2B and B2D business model. Its revenue comes from Licensing, Product Sales and Service Fee.

Beech Tree Labs, Inc. has approximately 1 employees.

Beech Tree Labs, Inc. has completed 2 funding rounds, raising a total of $8.46M. The latest funding stage is Series B.

Beech Tree Labs, Inc. offers: Discovery Research, Biome Regulation, Therapeutic Development, Clinical Trials Management, Licensing Partnership.

Top alternatives and competitors to Beech Tree Labs, Inc. include Click Therapeutics, Inc., ImmunoMet Therapeutics, Inc., Pharmamel Drug Discovery, Jazz Pharmaceuticals, Recursion. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Beech Tree Labs, Inc. and Click Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Beech Tree Labs, Inc.

Services & Products

Target Customers

Funding Rounds & Investors (2)

Beech Tree Labs, Inc. Alternatives & Competitors

FAQ About Beech Tree Labs, Inc.